Healthcare

Popular Topics in Healthcare

Subscribe to Updates in Healthcare

By RSS

The Expertise Imperative and Compliance Technology: Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework

This page may include content provided by Council Members, your access to which is subject to the Terms of Use.

Find Out More

October 19, 2007

A can of tennis balls?

Analysis of: Pfizer Abandons Exubera, Posts 77% Earnings Decline | online.wsj.com

This analysis is solely the work of the author. It has not been edited or endorsed by GLG.

Analysis By:

David Zimmerman, PharmD
President/Owner, Doctors of Pharmacy, Inc.

Implications: Exubera is a great product. However, the delivery system was difficult to use and educate the patients how to use. Hopefully, the next generation of the product will be in a smaller more user friendly cannister.

Analysis: Inhaled insulin should be a great product for diabetics.

Other Analyses of the Same Source Article:

Perhaps the Most Important Reason for Exubera Failure is that No One Wanted to Pay for it: October 29, 2007, Author: Dea Belazi, PharmD, MPH, PAHM, Pharmacy Consultant, Dea Belazi, PharmD, MPH, PAHM

Let's all exhale: October 26, 2007, Author: GLG Expert Contributor

Lessons for Product Profile Creation: October 24, 2007, Author: Evan Siegel, MPhil, PhD, President and Chief Executive Officer, Ground Zero Pharmaceuticals, Inc.

Exubera - approvable is no longer reimbursable: October 24, 2007, Author: David Sykes, Principal, PRMA Consulting Ltd

Lessons to Be Learned: Farewell to Exubera: October 23, 2007, Author: GLG Expert Contributor

Exit Exubera: October 22, 2007, Author: Tim Gallagher, RPh, Executive Vice President of Pharmacy Operations , Astrup Drug, Inc.

Pfizer Learns a Valuable - and Expensive - Lesson: October 22, 2007, Author: GLG Expert Contributor

inhaled insulin: October 22, 2007, Author: GLG Expert Contributor

Pfizer (PFE-N) Reinvents and then Opens a New Pandora's Box: October 22, 2007, Author: GLG Expert Contributor

Pfizer abandons exubera: October 22, 2007, Author: GLG Expert Contributor

Pfizer Stumbles.....but the concept of non-injectable insulin is a good one!: October 19, 2007, Author: GLG Expert Contributor

Report a Concern

More GLG News in
Healthcare

GLG News: What Experts Think Is Important

Generated at 2008-09-04T21:45:16.757

October 19, 2007

A can of tennis balls?

More GLG News inHealthcare

GLG News: What Experts Think Is Important

More GLG News in
Healthcare